{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:08:17Z","timestamp":1788822497080,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07194-7","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:42:25Z","timestamp":1782204145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent and unusual infections unmasking a rare inborn error of immunity: a case report RAS-associated Autoimmune Lymphoproliferative Disease (RALD)"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohamad Qazreen","family":"Ahmad Shawaludin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Anas Che","family":"Nik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarina Thasneem","family":"Zainudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahisham","family":"Taib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intan Juliana","family":"Abd Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"7194_CR1","doi-asserted-by":"publisher","unstructured":"Kindle G, Alligon M, Albert MH, Buckland M, Edgar JD, Gathmann B et al. Inborn errors of immunity: manifestation, treatment, and outcome \u2013 an ESID registry 1994\u20132024 report on 30,628 patients 2025. https:\/\/doi.org\/10.1101\/2025.02.20.25322586.","DOI":"10.1101\/2025.02.20.25322586"},{"key":"7194_CR2","doi-asserted-by":"publisher","unstructured":"Shah S, Wu E, Rao VK, Tarrant TK. Autoimmune lymphoproliferative syndrome: An update and review of the literature. Curr Allergy Asthma Rep. 2014;14. https:\/\/doi.org\/10.1007\/s11882-014-0462-4.","DOI":"10.1007\/s11882-014-0462-4"},{"key":"7194_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","volume":"41","author":"Q Neven","year":"2021","unstructured":"Neven Q, Boulanger C, Bruwier A, de Ville de Goyet M, Meyts I, Moens L, et al. Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD). J Clin Immunol. 2021;41:51\u20138. https:\/\/doi.org\/10.1007\/s10875-020-00883-7.","journal-title":"J Clin Immunol"},{"key":"7194_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5858\/arpa.2018-0190-RS","volume":"144","author":"DR Matson","year":"2020","unstructured":"Matson DR, Yang DT. Autoimmune lymphoproliferative syndrome an overview. Arch Pathol Lab Med. 2020;144:245\u201351. https:\/\/doi.org\/10.5858\/arpa.2018-0190-RS.","journal-title":"Arch Pathol Lab Med"},{"key":"7194_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2019.09.007","volume":"7","author":"A Singh","year":"2020","unstructured":"Singh A, Jindal AK, Joshi V, Anjani G, Rawat A. An updated review on phenocopies of primary immunodeficiency diseases. Genes Dis. 2020;7:12\u201325. https:\/\/doi.org\/10.1016\/j.gendis.2019.09.007.","journal-title":"Genes Dis"},{"key":"7194_CR6","doi-asserted-by":"publisher","unstructured":"Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA et al. Blood Spotlight JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities n.d. https:\/\/doi.org\/10.1182\/blood.","DOI":"10.1182\/blood"},{"key":"7194_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.prrv.2023.11.002","volume":"50","author":"O Jarrett","year":"2024","unstructured":"Jarrett O, Seng S, Fitzgerald DA. Paediatric melioidosis. Paediatr Respir Rev. 2024;50:31\u20137. https:\/\/doi.org\/10.1016\/j.prrv.2023.11.002.","journal-title":"Paediatr Respir Rev"},{"key":"7194_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2023.07.008","volume":"32","author":"ED Phillips","year":"2024","unstructured":"Phillips ED, Garcia EC. Burkholderia pseudomallei. Trends Microbiol. 2024;32:105\u20136. https:\/\/doi.org\/10.1016\/j.tim.2023.07.008.","journal-title":"Trends Microbiol"},{"key":"7194_CR9","doi-asserted-by":"publisher","unstructured":"Mohan A, Podin Y, Tai N, Chieng CH, Rigas V, Machunter B, et al. Pediatric melioidosis in Sarawak, Malaysia: Epidemiological, clinical and microbiological characteristics. PLoS Negl Trop Dis. 2017;11. https:\/\/doi.org\/10.1371\/journal.pntd.0005650.","DOI":"10.1371\/journal.pntd.0005650"},{"key":"7194_CR10","doi-asserted-by":"publisher","unstructured":"Dorman SE, Gill VJ, Gallin JI, Holland SM. Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis. 1998;26(4):889\u201394. https:\/\/doi.org\/10.1086\/513928.","DOI":"10.1086\/513928"},{"key":"7194_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00431-005-0022-y","volume":"165","author":"R Renella","year":"2006","unstructured":"Renella R, Perez JM, Chollet-Martin S, Sarnacki S, Fischer A, Blanche S, et al. Burkholderia pseudomallei infection in chronic granulomatous disease. Eur J Pediatr. 2006;165:175\u20137. https:\/\/doi.org\/10.1007\/s00431-005-0022-y.","journal-title":"Eur J Pediatr"},{"key":"7194_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","volume":"26","author":"J Bustamante","year":"2014","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity. Semin Immunol. 2014;26:454\u201370. https:\/\/doi.org\/10.1016\/j.smim.2014.09.008.","journal-title":"Semin Immunol"},{"key":"7194_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","volume":"123","author":"MA Spinner","year":"2014","unstructured":"Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, et al. GATA2 deficiency: A protean disorder of hematopoiesis, lymphatics, and immunity. Blood. 2014;123:809\u201321. https:\/\/doi.org\/10.1182\/blood-2013-07-515528.","journal-title":"Blood"},{"key":"7194_CR14","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Gomez ML, Becerra JCA, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154\u201364. https:\/\/doi.org\/10.1182\/blood-2015-11-679902.","journal-title":"Blood"},{"key":"7194_CR15","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176\u201383. https:\/\/doi.org\/10.1093\/cid\/ciu1154.","journal-title":"Clin Infect Dis"},{"key":"7194_CR16","doi-asserted-by":"publisher","unstructured":"Cicenas J, Tamosaitis L, Kvederaviciute K, Tarvydas R, Staniute G, Kalyan K, et al. KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma. Med Oncol. 2017;34. https:\/\/doi.org\/10.1007\/s12032-016-0879-9.","DOI":"10.1007\/s12032-016-0879-9"},{"key":"7194_CR17","doi-asserted-by":"publisher","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): Report from the 2009 NIH International Workshop. Blood, vol. 116, American Society of Hematology; 2010. https:\/\/doi.org\/10.1182\/blood-2010-04-280347","DOI":"10.1182\/blood-2010-04-280347"},{"key":"7194_CR18","doi-asserted-by":"publisher","unstructured":"Wang W, Zhou Y, Zhong L, Wang L, Tang X, Ma M, et al. RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: A case series of RALD in Chinese children. Pediatr Rheumatol. 2019;17. https:\/\/doi.org\/10.1186\/s12969-019-0346-1.","DOI":"10.1186\/s12969-019-0346-1"},{"key":"7194_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cei.12986","volume":"189","author":"S Levy-Mendelovich","year":"2017","unstructured":"Levy-Mendelovich S, Lev A, Rechavi E, Barel O, Golan H, Bielorai B, et al. T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing. Clin Exp Immunol. 2017;189:310\u20137. https:\/\/doi.org\/10.1111\/cei.12986.","journal-title":"Clin Exp Immunol"},{"key":"7194_CR20","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","volume":"72","author":"IA Prior","year":"2012","unstructured":"Prior IA, Lewis PD, Mattos C. A comprehensive survey of ras mutations in cancer. Cancer Res. 2012;72:2457\u201367. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2612.","journal-title":"Cancer Res"},{"key":"7194_CR21","doi-asserted-by":"publisher","unstructured":"Lo \u0301 pez-Nevado M, Gonza \u0301lez-GranadoLI R-G, \u0301\u0131aR, Pleguezuelo D, Cabrera-Marante O et al. Salmo \u0301 n N,. (2021) Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. Front. Immunol. 12:671755. https:\/\/doi.org\/10.3389\/fimmu.2021.671755","DOI":"10.3389\/fimmu.2021.671755"},{"key":"7194_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355\u201369. https:\/\/doi.org\/10.1146\/annurev-genom-091212-153523.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"7194_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BCJ20220234","volume":"480","author":"W Kolch","year":"2023","unstructured":"Kolch W, Berta D, Rosta E. Dynamic regulation of RAS and RAS signaling. Biochem J. 2023;480:1\u201323. https:\/\/doi.org\/10.1042\/BCJ20220234.","journal-title":"Biochem J"},{"key":"7194_CR24","doi-asserted-by":"publisher","unstructured":"Oliveira JB, Bid\u00e8re N, Niemela JE, Zheng L, Sakai K, Nix CP, Danner RL, Barb J, Munson PJ, Puck JM, Dale J, Straus SE, Fleisher TA, Lenardo MJ. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci USA. 2007;104(21):8953\u20138. https:\/\/doi.org\/10.1073\/pnas.0702975104.","DOI":"10.1073\/pnas.0702975104"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07194-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07194-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07194-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:35:12Z","timestamp":1788820512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-07194-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7194"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07194-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. This study was approved by the Human Research Ethics Committee, USM (JEPeM), USM\/JEPeM\/22090600. The written informed consent to participate has been obtained from the parent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The written informed consent for publication has been obtained from the parent.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"838"}}